The ASA Poster Travel Award
This is awarded to an individual on the basis of a poster presented during the ASA’s Annual Scientific Meeting.
The applicant must have been a financial member of the ASA for at least the last twelve months. The award committee will consist of three ASA committee members or their nominees and will take into account the quality and originality of the poster.
The award consists of a return economy airfare, accommodation and conference registration up to the value of AUD2,500 for the recipient to attend ASA Annual Scientific Meeting.
Antimicrobials 2024 ASA Poster Travel Award Recipients
Sydney International Convention Centre, Sydney, New South Wales
15 – 17 February 2024
Auriane Form, Murdoch University. Diversity of Van Operons in Vancomycin Variable Enterococcus Faecim causing Bacteraemia from Australia, 2016 – 2020.
Antimicrobials 2023 ASA Poster Travel Award Recipients
Brisbane Convention and Exhibition Centre, Brisbane, Queensland
23 – 25 February 2023
Sara Horsman, University of Queensland. Identification and Antimicrobial Resistance of Bacterial Isolates Cultured from Clinical Canine Skin and ear Samples in Queensland.
Antimicrobials 2020 ASA Poster Travel Award Recipients
Melbourne Convention and Exhibition Centre, Melbourne, Victoria
27 – 29 February 2020
Melinda Ashcroft. University of Melbourne, Victoria. Limited Intra-patient Variability in Neisseria gonorrhoeae from Multiple Anatomical Sites: Implications for Understanding Transmission.
Antimicrobials 2019 ASA Poster Travel Award Recipients
Sheraton Grand Sydney Hyde Park, Sydney New South Wales
21 – 23 February 2019
Kyra Chua. Dorevitch Pathology and Austin Health, Victoria. Individual and Community Predictors of Ceftriaxone Resistant Escherichia coli Isolates, Victoria Australia
Antimicrobials 2018 ASA Poster Travel Award Recipients
Brisbane Exhibition and Convention Centre, Brisbane Queensland
22 – 24 February 2018
Evette Buono. Clinical Excellence Commission, New South Wales. Drop the lines go to oral in time!
The ASA Travel Awards
ASA has made funds available for travel awards to assist Members wanting to attend the Society’s annual scientific meeting. Awards are made to ASA financial members presenting a proffered paper (oral or poster) at the meeting. Applicants must have current ASA membership and must have been ASA members for at least the last 12 months. Recipients of an Award are required to write a report on the meeting for the ASA Newsletter.
The awards consist of a return economy airfare, accommodation and conference registration up to the value of AUD2,500.
ASA members who wish to apply for this award are invited to submit their application to ASA Secretary Denise Daley at info@asainc.net.au. The application should include a copy of the abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.
Antimicrobials 2024 ASA Travel Award Recipients
Sydney International Convention Centre (Sydney ICC)
15 – 17 February 2024
Adam Steward. The University of Queensland – “Third-Generation Cephalsporin-Resistant Klebsiella Pneumoniae Complex Bloodstream Infection in Adult Patients: Changing Epodemiology and Determinants of Poor Outcomes.”
Abiodun Ogunniyi (David). The University of Adelaide – “Bioluminescent Mouse Models of Bacterial Infection to Test Efficacy of New Drug Classes Against Multidrug-REsistant Bacterial Pathogens.”
Nicholas Yee. Murdoch University – “Genomic characterisation of ST1232-V CC398 MRSA Isolated in Western Australia”
Antimicrobials 2023 ASA Travel Award Recipients
Brisbane Convention and Exhibition Centre, Brisbane, Queensland
23 – 25 February 2023
Candice Lim. Murdoch University – “Investigating the Genetic Factor(s) Responsible for Daptomycin Resistance in Staphylococcus aureus isolated in Australia”
Katharina Richter. The University of Adelaide – “Validating Plasma-Treated Water as a Wound Cleanser in a Murine Bioluminescent MRSA Infection Mode”
Antimicrobials 2020 ASA Travel Award Recipients
Melbourne Convention and Exhibition Centre, Melbourne, Victoria
27 – 29 February 2020
Aaron Heffernan. Griffith University, Queensland. A dose-ranging pharmacodynamic evaluation of plasma and epithelial lining fluid exposures of amikacin against Pseudomonas aeruginosa in a dynamic in vitro hollow-fiber infection model
Shakeel Mowlaboccus. Murdoch University, Western Australia. Genomic Evolution of penicillin-resistant Neisseria meningtidis clone in Western Australia
Yi Nong. The University of Melbourne, Victoria. Dissecting the role of topical antibiotic use in the emergence of multidrug-resistant Staphylococcus aureus
Stanley Pang. Murdoch University, Western Australia. Applying genome-wide association studies to understand the genetic variation in ST93 MRSA
Antimicrobials 2019 ASA Travel Award Recipients
Sheraton Grand Sydney Hyde Park, Sydney, New South Wales
21 – 23 February 2019
Iain Abbott. Monash University, Victoria. Oral fosfomycin ineffective against K. pneumoniaeuropathoegens in a dynamic bladder infection in vitro model
Bronwyn Achemedei. Murdoch University, Western Australia. The phylogeny of ST1-MRSA-IV isolated in remote Western Australian communities
Riley Murphy. Curtin University, Western Australia. Multiple introductions of methicillin-resistant Staphylococcus aureus ST612 into Western Australia associated with both human and equine reservoirs
Antimicrobials 2018 ASA Travel Award Recipients
Brisbane Exhibition and Convention Centre, Brisbane Queensland
22 – 24 February 2018
Sam Abraham. Murdoch University, Western Australia. Australian Silver Gulls (Chroicocephalus novaehollandiae) are carriers of pathogenic, globally disseminated, pandemic and critically important antimicrobial resistant Escherichia coli
Daniel Knight. Murdoch University, Western Australia. Antimicrobial resistance in zoonotic lineages of Clostridium difficle
Terence Lee. Murdoch University, Western Australia.Characterization of ST173 vanB E. faecium from the first VRE outbreak in Western Australia
Antimicrobials 2017 ASA Travel Award Recipients
Adelaide Convention Centre, Adelaide, South Australia
23 – 25 February 2017Sarah Baines. The University of Melbourne, Victoria, Australia. Evolving chlorhexidine tolerance with a prevalent hospital lineage of methicillin-resistant Staphylococcus aureus
Kate Worthing. University of Sydney, New South Wales, Australia. Characterisation of novel SCCmec elements from methicillin-resistant Staphylococcus pseudintermedius from Australian animals
Indy Sandaradura. Westmead Hospital, New South Wales, Australia. Computerised fluconazole dose selection in critical illness
Antimicrobials 2016 ASA Travel Award Recipients
Melbourne Convention Centre, Melbourne, Victoria
25 – 27 February 2016
Josh Ramsay. Curtin University, Western Australia, Australia. Resolving the enigma of methicillin-resistance transfer in Staphylococcus aureus
Edward Raby. Fiona Stanley Hospital, Western Australi. Zoonotic transmission of the methicillin-resistant Staphylococcus aureus ST612-IV equine strain
Terence Lee. Murdoch University, Western Australia. The vancomycin LECOFF and vanB subtypes of E. faecium isolated in Australia
Antimicrobials 2015 ASA Travel Award Recipients
Brisbane Exhibition and Convention Centre, Brisbane Queensland
26 – 28 February 2015
Josh Ramsay. Curtin University, Western Australia, Australia. The Majority of Multidrug-resistance Plasmids in Staphylococcus aureus Carry Origin-of-Transfer Sequences that are Mobilisable by Conjugative Plasmids
Jason Kwong. University of Melbourne, Victoria, Australia. Whole Genome Sequencing Indicates Local Transmission of KPC-2 Producing Klebsiella pneumoniae in a Victoria-wide Outbreak
Sam Abraham. University of Adelaide, South Australia, Australia. First Detection of Extended-spectrum Cephalosporin and Fluoroquinolone-Resistant Pathogenic Escherichia coli in Australian Food-producing Animals, Representing Internationally Disseminated, Multidrug-resistant Zooanthroponotic Clonal Lineages
Antimicrobials 2014 ASA Travel Award Recipients
Melbourne Convention Centre, Melbourne, Victoria
20 – 22 February 2014
Janet Montgomery. Austin Health, Victoria, Australia. Phenotypic Detection of Carbapenemase Producing Gram Negative Bacilli: Which Method is Better?
Wei Gao. Austin Centre for Infection Research, Victoria, Australia. Genomics of Persistent Staphylococcus aureus Infection.
Hanna Sidjabat. The University of Queensland Centre for Clinical Research, Queensland, Australia.Increasing Emergence of IMP-4 Producing Enterobacteriaceae throughout Queensland Hospitals.
Elizabeth Witherden. University of Tasmania, Tasmania, Australia. The Role of Inter-species Recombination of the ftsI Gene on the Dissemination of Altered Penicillin-binding Protein 3 Mediated Resistance in Haemophilus influenzae and Haemophilus haemolyticus.
Antimicrobials 2013 ASA Travel Award Recipients
Sofitel Sydney Wentworth, Sydney, New South Wales
21 – 23 February 2013
Natasha Holmes. Austin Centre for Infection Research, Austin Health, Victoria, Australia. Development of Teicoplanin Resistance in vanB Vancomycin-Resistant Enterococcus faecium during Treatment for Infections in Solid Organ Transplant Recipients
Steven Tong. Menzies School of Health Research, Northern Territory, Australia. Whole Genome Sequencing of ST239-MRSA and the Influence of Within-Host Clouds of Variation
Margaret Lam. University of Melbourne, Victoria, Australia. Using Genomics to Understand the Success of ST230 Vancomycin Resistant Enterococcus faecium
Antimicrobials 2012 ASA Travel Award Recipients
Brisbane Exhibition and Convention Centre, Brisbane Queensland
23 – 25 February 2012
Natasha Holmes. Austin Centre for Infection Research, Austin Health, Victoria. Searching for Organism Factors that may Explain the Association between Elevated Vancomycin Minimum Inhibitory Concentration and Mortality in Staphylococcus aureus Bacteraemia.
Kyra Chua. University of Melbourne, Victoria. Why is Australian Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) ST93-IV [2B] Highly Virulent?
Deborah Williamson. Auckland District Health Board, New Zealand. Sequence Type (ST) 131 Escherichia coli as a Major Cause of Bacteraemia Following Transrectal Ultrasound-guided Prostate Biopsy
Antimicrobials 2011 ASA Travel Award Recipients
Hilton on the Park, Melbourne Victoria
24 – 26 February 2011
Hanna Sidjabat. University of Queensland, Australia. Molecular Epidemiology of Cephalosporinase Encoding Plasmids in Escherichia coli
Andrew Bowen. Southern IML Pathology, Australia. Measurement Uncertainty and the CDS Method
Antimicrobials 2010 ASA Travel Award Recipients
Sofitel Sydney Wentworth Hotel, Sydney New South Wales
25 – 27 February 2010
Stephen Tristram. University of Tasmania, Australia. Screening and Identifying BLNAR and BLPACR Strains of H. influenzae.
Natasha Holmes. Austin Health, Australia. Vancomycin Minimum Inhibitory Concentration (MIC) in Australian Staphylococcus aureus Bactaeraemia (SAB) – An Australian and New Zealand Cooperative on Outcomes in Staphylococcal Sepsis (ANZCOSS) Substudy.
Steven Tong. Menzies School of Health Research, Northern Territory, Australia. Molecular Detection of the H275Y Oseltamivir Resistance Mutation in Influenza A/H1N1 2009 by Step-Down RT-PCR and SYBR Green High-Resolution Melting Analysis.
Antimicrobials 2009 ASA Travel Award Recipients
Hilton on the Park, Melbourne Victoria
26 – 28 February 2009
Peter Huntington. Royal North Shore Hospital, Australia. An Agar Dilution Method for Detection of Metallo-beta-lactamase Producing Enterobacteriaceae, Pseudomonas and Acinetobacter.
Vicki McNeil. Department of Health, South Australian Government, Australia. Use of DU90% Method to Assess Antimicrobial Usage by National Antimicrobial Utilisation Surveillance Program (NAUSP) Contributors.
Lee Thomas. Westmead Hospital, New South Wales. A Comparison of Three Commercial Available Chromogenic Media for the Rapid Detection of MRSA.
Antimicrobials 2008 ASA Travel Award Recipients
Stamford Plaza Double Bay, Sydney New South Wales
21 – 23 February 2008
Catherine Bennett. University of Melbourne, Australia. More Common than we thought? Methicillin Resistance and PVL in Community-Onset Staphylococcus aureus Infections in Melbourne.
Janet Montgomery. Austin Hospital, Australia. Comparison of Phenotypic Tests for Detection of Plasmid Mediated AmpC-Mediated Beta-lactamases.
Antimicrobials 2007 ASA Travel Award Recipients
Rydges Melbourne, Melbourne Victoria
22 – 24 February 2007
Steven Tong. Royal Darwin Hospital, Australia. Community-Associated Methicillin-
Resistant Staphylococcus aureus: A Prospective Case-Cohort Study in Northern
Australia.
Stephen Tristram. University of Tasmania, Australia. TEM-15 ESBL and Altered PBP3 in Multi-
Resistant Strains of Haemophilus influenzae.
Nicholas Biehl. University of Western Australia, Australia. Community-Onset MRSA Infection:
A Survey of Knowledge and Behaviour of Western Australian General Practitioners.
Antimicrobials 2006 ASA Travel Award Recipients
Crowne Plaza, Coogee Beach, Sydney NSW
23 – 25 February 2006
Kate Dollman. South Australia Department of Health, Australia. National Antimicrobial
Utilisation Surveillance.
Elizabeth Grabsch. Austin Health. Australia. Oxgall Supplement to Mueller-Hinton and Brain-
Heart Infusion Agar Improves the Routine Identification of Low-MIC Vancomycin-Resistant
Enterococci (LM-VRE).
Antimicrobials 2005 ASA Travel Award Recipients
Cumberland Lorne Resort, Lorne Victoria
24 – 26 February 2005
Sreeja Sudhakaran. Monash University. Australia. Inhibition of P-Glycoprotein Mediated
Efflux: A Mechanism to Increase Indinavir Transfer to the Foetus.
Matthew Rawlins, Royal Perth Hospital, Australia. Assessing the Impact of an Antimicrobial
Stewardship Programme Round at a WA Teaching Hospital.
Antimicrobials 2004 ASA Travel Award Recipients
Novotel Brighton-Le-Sands, Sydney NSW
26 – 28 February 2004
Frances O’Brien. Curtin University. Australia. Plasmid Encoded Fusidic Acid Resistance in Staphylococcus aureus
Tom Solano. Royal Prince Alfred Hospital. Australia. Comparison of Antibiotic Dispensing Data
Versus Administration Data in Intensive Care.
Stephen Tristram. University of Tasmania. Australia. Disc Diffusion Based Screening Tests for
Extended Spectrum Beta Lactamases in Haemophilus influenzae.
Sophia Tan.University of South Australia. Australia Macrolide, lincosamide and streptogramin
resistance in E.faecium
The ASA ISSSI Travel Scholarship
ISSSI 2024
Perth, Australia
18 – 24 August 2024
The Australian Society for Antimicrobials (ASA), has made funds available to assist ASA Members who are preferably a PhD student or an advanced trainee who will be presenting at the 2020 International Symposium on Staphylococci and Staphylococcal Infections (ISSSI). Up to five travel awards will be available.
Each successful awardee will be granted 1,000 AUD towards the cost of their travel to Perth and their accommodation, as well as a free symposium registration. They will also be presented with an award certificate during the symposium.
The awards will be based on the abstract submitted by an applicant who should be the presenting author (poster or oral presentation)
Applicants must have current ASA membership and must have been an ASA member for at least the last 12 months. The scholarship is restricted to Australian, South East Asian and New Zealand ASA financial members and is conditional upon the abstract being accepted by the ISSSI program committee for presentation. In addition the recipient of the award is required to write a report on the meeting for the ASA Newsletter.
Eligible ASA members who wish to apply for an award are invited to submit their application to the ASA Secretary Denise Daley at info@asainc.net.au. The application should include a copy of their abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.
ISSSI 2018 Travel Scholarship Recipient
Copenhagen, Denmark
23 – 26 August 2018
Sarah Baines. The University of Melbourne. Australia. Comprehensive Genomic Investigation of Staphylococcus aureus Bacteraemia in Australia
Stanley Pang. Murdoch University, Australia. Genetic Diversity and Geographical Distribution of Bactereamic Methicillin-resistant Staphylocococcus aureus in Australia
ISSSI 2014 Travel Scholarship Recipient
Chicago, USA
26 – 29 August 2014
Josh Ramsay. Curtin University. Australia. Conjugative Mobilisation of Diverse Antimicrobial-resistance and Virulence Gene Plasmids by the pWBG749 Family of Conjugative Plasmids
ISSSI 2012 Travel Scholarship Recipient
Lyon, France
26 – 30 August 2012
Wei Gao. Austin Hospital. Australia. Subtle Changes in Clinical Staphylococcus aureus Promote Co-resistance to Antimicrobials and Innate Immune Response
ISSSI 2010 Travel Scholarship Recipient
Bath, United Kingdom
6 – 9 September 2010
Kyra Chua. Austin Hospital. Australia. Understanding Increased Virulence of ST93-MRSA-IV, A Unique Australian Clone of Community Methicillin-Resistant Staphylococcus aureus“
The bioMerieux ASA Identifying Resistance Travel Award
This is awarded to an individual on the basis of a proffered paper (oral or poster) presented during the ASA’s Annual Scientific Meeting dealing with the identification of antimicrobial resistance.
The applicant must be a financial member of the ASA. The Award is restricted to ASA members residing in Australia or New Zealand. The award will take into account the quality and originality of the paper.
The award consists of AU$1,000 cash prize, a commemorative plaque, and the provisions of flights, accommodation and registration for the recipient to attend Antimicrobials 2022. The award committee will consist of three ASA committee members or their nominees.
Antimicrobials 2024 bioMerieux ASA Identifying Resistance Travel Award Recipient
Sydney International Convention Centre, Sydney, New South Wales
15 – 17 February 2024
| Nicola Woodfield, Melbourne Pathology A Comparison of Methods for the Screening and Detection of CRE/CPO in The Laboratory |
Antimicrobials 2023 bioMerieux ASA Identifying Resistance Travel Award Recipient
Brisbane Convention and Exhibition Centre, Brisbane, Queensland
23 – 25 February 2023
| Shalinie Perera, Western Diagnostic Pathology Comparison of the Etest with the Sensititre YeastOne Assay for Fluconazole Susceptibility in Candida species |
Antimicrobials 2020 bioMerieux ASA Identifying Resistance Travel Award Recipient
Melbourne Convention and Exhibition Centre, Melbourne, Victoria
27 – 29 February 2020
| Joanne Teh, Flinders Medical Centre, South Australia Antimicrobial Susceptibility Testing for Staphylococcus lugdunensis |
Antimicrobials 2019 bioMerieux ASA Identifying Resistance Travel Award Recipient
Sheraton Grand Sydney Hyde Park, Sydney New South Wales
21 – 23 February 2019
| Frances Hurren, Austin Health, Victoria Evaluation of the Carbapenem Inactivation Method (CIM) as a Predictor for Carbapenemase-producing Gram Negative Bacteria |
Antimicrobials 2018 bioMerieux ASA Identifying Resistance Travel Award Recipient
Brisbane Exhibition and Convention Centre, Brisbane Queensland
22 – 24 February 2018
| Shelanah Fernando, Concord Hospital, New South Wales Increasing Ampicillin and Amoxycillin-clavulanate Resistance in Haemophilus influenzae in Australia: A Comparison of Detection using EUCAST, CLSI and CDS methods |
Antimicrobials 2017 bioMerieux ASA Identifying Resistance Travel Award Recipient
Adelaide Convention Centre, Adelaide
23 – 25 February 2017
Frances Hurren, Austin Hospital, Victoria
The Carbapenem Inactivation Method (CIM) for the Detection of OXA Enzymes in Gram-Negative Bacteria
Antimicrobials 2016 bioMerieux ASA Identifying Resistance Travel Award Recipient
Melbourne Convention Centre, Melbourne
25 – 27 February 2016
Nicola Townell, Sullivan Nicolaides, Queensland
Detection of Beta-lactam Resistance in Enterobacteriaceae using the MALDI-TOF MS
Antimicrobials 2015 bioMerieux ASA Identifying Resistance Travel Award Recipient
Brisbane Exhibition and Convention Centre, Brisbane
26 – 28 February 2015
Karen Lawry, Auckland District Health Board, New Zealand
Laboratory Detection of Carbapenemase-Producing Enterobacteriaceae: Evaluation of pheotypic and Molecular Methods
Antimicrobials 2014 bioMerieux ASA Identifying Resistance Travel Award Recipient
Melbourne Convention Centre, Melbourne
20 – 22 February 2014Lai-Yang Lee, Monash Health, Victoria.Rapid Time to Results for Carba NP Test from Early Culture Growth Associated with Improved Sensitivity for Detection of Carbapenemase Producers among Carbapenem Non-susceptible Gram-negative Bacilli
Antimicrobials 2013 bioMerieux ASA Identifying Resistance Travel Award Recipient
Sofitel Sydney Wentworth Hotel, Sydney
21 – 23 February 2013
Linda Joyce, St Vincents Hospital, Victoria.
Comparison of Direct Blood Culture Identification and Antibiotic Sensitivity Test Results with Confirmatory Result
Antimicrobials 2012 bioMerieux ASA Identifying Resistance Travel Award Recipient
Brisbane Exhibition and Convention Centre, Brisbane
23 – 25 February 2012
Hanna Sidjabat, University of Queensland Centre for Clinical Research, Queensland.
Development of Multiplex PCR: B-lactamase Genes and Viruelence Determinants in E.coli
Antimicrobials 2011 bioMerieux ASA Identifying Resistance Travel Award Recipient
Hilton on the Park, Victoria
24 – 26 February 2011
Susan Grima, Southern Cross Pathology. Australia.
Direct Antimicrobial Susceptibility Testing of Enterococci from Urine Samples
Antimicrobials 2010 bioMerieux ASA Identifying Resistance Travel Award Recipient
Sofitel Sydney Wenworth Hotel, Sydney
25 – 27 February 2010
Paul Ingram. PathWest Laboratory Medicine – WA (Sir Charles Gairdner Hospital)
Detection of AmpC Beta-lactamases Using a Novel Etest Strip
Antimicrobials 2009 bioMerieux ASA Identifying Resistance Travel Award Recipient
Hilton on the Park, Victoria
26 – 28 February 2009
Justin Ellem, Westmead Hospital. Australia.
Comparison and Evaluation of a Newly Developed Mast 4-Disc Test for the Detection of Plasmid-Mediated AmpC Beta-lactamases
Antimicrobials 2008 bioMerieux ASA Identifying Resistance Travel Award Recipient
Stamford Double Bay, New South Wales
21 – 23 February 2008
Janet Montgomery, Austin Health. Australia.
Comparison of Phenotypic Tests for Detection of Plasmid-Mediated AmpC Beta-lactamases
Antimicrobials 2007 bioMerieux ASA Identifying Resistance Travel Award Recipient
Rydges Melbourne, Melbourne, Victoria
22 – 24 February 2007
Cheryll McCullough, PathWest Laboratory Medicine WA – Royal Perth Hospital, Australia.
Phenotypic Confirmation of Extended Spectrum B-lactamases in Enterobacteriacae Using
Commercially Prepared Diffusion Systems
Antimicrobials 2006 bioMerieux ASA Identifying Resistance Tracel Award Recipient
Crowne Plaza, Coogee Beach, Sydney NSW
23 – 25 February 2006
Jacqueline Schooneveldt, Queensland Health Pathology Services, Australia.
MRSA Screenung Using the Tube Coagulase on Selective Enrichment Broth and Real Time PCR
Versus Proprietary RT PCR (IDI-MRSA)
Antimicrobials 2005 bioMerieux ASA Identifying Resistance Travel Award Recipient
Cumberland Lorne Resort, Lorne Victoria
24 – 26 February 2005
Jacqueline Harper, Queensland Health Pathology Services, Australia.
Routine Tests for Detection of mecA-mediated Resistance in Staphylococcus aureus
Antimicrobials 2004 bioMerieux ASA Identifying Resistance Travel Award Recipient
Novotel Brighton-Le-Sands, Sydney NSW
26 – 28 February 2004
Janet Montgomery. Austin Health. Australia
Accuracy of Routine Detection of Oxacillin Resistance in Clinical Staphylococcus aureus
Antimicrobials 2003 bioMerieux ASA Identifying Resistance Travel Award Recipient
Hilton on the Park, Melbourne VIC
1 – 3 May 2003
Cheryll McCullough. Royal Perth Hospital, Australia
The Inability of NCCLS Disc Diffusion Oxacillin Interpretive Breakpoint for S aureus to Reliably Detect Oxacillin-Susceptible Staphylococcus lugdunensisASA AstraZeneca ECCMID Travel Award
ECCMID 2011 AstraZeneca Travel Award Recipient
Milan, Italy
Anton Peleg. Monash University, Australia.
A Novel Mechanism of Reduced Susceptibility to Vancomycin in Staphylococcus aureusASA AstraZeneca ICAAC Travel Award
ICAAC 2010 AstraZeneca Travel Award Recipient
Boston, USA
Christopher Blyth. The University of Western Australia, Australia.
Bacterial and Viral Coinfections in Severe Influenza Infections 2009
ICAAC 2009 AstraZeneca Travel Award Recipient
San Francisco, USA
Douglas Johnson. Austin Hospital, Australia.
Neutralising Antibody Responses to a Recombinant Mammalian Cell Derived Hepatitis C (HCV) Virus Like particle Vaccine
ICAAC 2008 AstraZeneca Travel Award Recipient
Washington, USA
Anton Peleg. Beth Israel Deaconess Medical Centre, Boston, USA
Relationship between Virulence and Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Galleria mellonella as a Model System to Study Acinetobacter baumannii Pathogenesis and Therapeutics
Catherine Bennett. The University of Melbourne, Australia
Patient and Infection Characteristics Associated with the Presence of pvl in Community Onset Staphylococcus aureus Infections in Melbourne, Australia
ICAAC 2007 AstraZeneca Travel Award Recipient
Chicago, USA
Julie Pearson. PathWest Laboratory Medicine WA – Royal Perth Hospital, Australia
Detection of International Panton-Valentine Leucocidin (PVL) Positive CA-MRSA Clones in Western Australia
ICAAC 2006 AstraZeneca Travel Award Recipient
San Francisco, USA
Ben Howden. Austin Health, Australia
Whole Genome Comparison of a Vancomycin-Susceptible Staphylococcus aureus (VSSA) and a Vancomycin-Intermediate Derivative (VISA) Obtained from a Patient with Vancomycin Treatment Failure
ICAAC 2005 AstraZeneca Travel Award Recipient
Washington DC, USA
Jian Li. Monash University, Australia
In vitro Pharmacodynamics (PD) of Colistin and Colistin Methanesulfonate (CMS) agaianst Acinetobacter baumannii
ICAAC 2004 AstraZeneca Travel Award Recipient
Washington DC, USA
Ben Howden. Austin Health, Australia
Identification of a New Agar Dilution Screening Method for the Accurate Detection of Heterogenous-Vancomycin Intermediate Staphylococcus aureus (hVISA).
ICAAC 2003 AstraZeneca Travel Award Recipient
Chicago, USA
Sue Ballard. Austin Health, Australia
Correlating the Detection of vanB Genes in Faeces to the Presence of Vancomycin Resistant Enterococci (VRE): Interference by vanB containing Anaerobes
ICAAC 2002 AstraZeneca Travel Award Recipient
San Diego, USA
Ian Kay. Royal Perth Hospital, Australia
Performance of a Real-time Multiplex PCR Assay versus Culture for the Rapid Detection of vanA and vanB Genes Directly from Clinical Specimens